Research - Regeneron’s (REGN) Praluent has been approved by the FDA, and the label essentially meets the Base Case scenario that we wrote about yesterday for Esperion … Continue Reading
Premium: Read NowResearch - Cempra (CEMP) announced on Tuesday that enrollment in the phase III SOLITAIRE-IV trial is complete, and the company expects data from the study in the … Continue Reading
Read NowResearch - PCDH19 female epilepsy is associated with low levels of allopregnanolone in the blood, a neurosteroid, hormone metabolite, and a positive allosteric modulator of the GABAa receptor.
Premium: Read NowzPremium - Greece unknowns weigh on the market going into the holiday weekend (Happy fourth by the way!), but the referendum on Sunday should offer some perspective … Continue Reading
Premium: Read NowResearch - Shares of Sage Therapeutics (SAGE) climbed higher on Tuesday with the first glimpse at SAGE-547’s potential in post-partum depression. And with it went Marinus Pharmaceuticals … Continue Reading
Read NowResearch - QLT Inc. (QLTI) finally made the move we had been waiting for – although it's perhaps not the move we had been hoping for.
Premium: Read NowResearch - Updates on our Affimed (AFMD), Innate Pharma (IPH), and Oncothyreon (ONTY) coverage coming away from ASCO 2015.
Premium: Read Now
